KPWS
WST icon

Kestra Private Wealth Services’s West Pharmaceutical WST Stock Holding History

Kestra Private Wealth Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,473
Closed -$363K – 998
2022
Q3 		$363K Sell
1,473
-819
-36% -$249K 0.02% 587
2022
Q2 		$693K Sell
2,292
-225
-9% -$73.2K 0.04% 415
2022
Q1 		$1.03M Sell
2,517
-853
-25% -$334K 0.05% 371
2021
Q4 		$1.58M Buy
3,370
+2,436
+261% +$1.05M 0.08% 282
2021
Q3 		$397K Buy
+934
New +$394K 0.02% 605

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kestra Private Wealth Services's WST Position: Q4 2022 in Review

Kestra Private Wealth Services sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 1,473 shares — an estimated $363K sold.

Kestra Private Wealth Services first reported a position in WST in Q3 2021 and held it in 5 quarters. The position peaked at $1.58M in Q4 2021. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Kestra Private Wealth Services reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Kestra Private Wealth Services sold 1,473 West Pharmaceutical shares in Q4 2022, an estimated $363K.
  • Kestra Private Wealth Services first reported a position in West Pharmaceutical in Q3 2021 and held it in 5 quarters.
  • Kestra Private Wealth Services's West Pharmaceutical position peaked at $1.58M in Q4 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Kestra Private Wealth Services's 13F filing for Q4 2022, filed 1 Feb 2023.